Keros Therapeutics Inc Sustainability Reports
Keros Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics for patients with disorders linked to dysfunctional signaling of the transforming growth factor-beta family of proteins.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00H1HP9H8
1 reports from 2023 to 2023
Company Profile
Keros Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics for patients with disorders linked to dysfunctional signaling of the transforming growth factor-beta family of proteins.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
